Literature DB >> 19668453

Cytomegalovirus retinitis presenting as vasculitis in a patient with Wegener's granulomatosis.

Paris G Tranos1, Ilias Georgalas, Panagiota Founti, Ioannis Ladas.   

Abstract

PURPOSE: To present an unusual case of cytomegalovirus (CMV) retinitis in a patient with Wegener's granulomatosis.
RESULTS: A 54-year-old lady with Wegener's granulomatosis presented with decreased vision in her left eye. Wegener's retinal vasculitis was diagnosed initially and the patient received treatment with oral steroids. Three days later the patient developed typical CMV retinitis.
CONCLUSION: The likelihood of CMV retinitis in patients with Wegener's granulomatosis should not be overlooked. Increased awareness in such cases is very important since CMV retinitis may present with less typical manifestations, which makes the correct diagnosis more challenging.

Entities:  

Keywords:  Wegener’s granulomatosis; cytomegalovirus retinitis; ganciclovir

Year:  2008        PMID: 19668453      PMCID: PMC2699776          DOI: 10.2147/opth.s4022

Source DB:  PubMed          Journal:  Clin Ophthalmol        ISSN: 1177-5467


Introduction

Cytomegalovirus (CMV) is the main cause of infectious retinitis in severely immunosuppressed hosts (Pertel et al 1992). Wegener’s granulomatosis is an immune-mediated disorder with frequent eye involvement. CMV retinitis is extremely uncommon in these patients and it may present with atypical characteristics posing diagnostic dilemmas. We present a case of CMV retinitis in a patient with Wegener’s granulomatosis which was diagnosed and treated initially as Wegener’s retinal vasculitis.

Case report

A 54-year-old female patient presented at the Ophthalmic clinic complaining of mild eye discomfort and gradual reduction of vision in her left eye over the previous 10 days. The patient had a history of meningitis in the past and surgery for removal of pituitary adenoma 13 years ago. Four years earlier she developed central nervous system vasculitis and was diagnosed with Wegener’s granulomatosis. At presentation the patient was immunosuppressed due to her treatment with methylprednizolone 5 mgr/day and cyclophosphamide 1.5 mgr/kg/day. On examination her best corrected visual acuity (BCVA) in the symptomatic left eye was 6/9–2. Blood tests and chest X-ray excluded other inflammatory conditions, however, CD-4 levels was 180/mm3. There was no activity from the anterior chamber, however, there was mild vitritis. B-mode ultrasound excluded scleritis with normal scleral thickness and fundoscopy revealed vasculitis and a few cotton wool spots in the peripapillary area and along the vascular arcades sparing the macula. At that time her clinical picture was consistent with Wegener’s retinal vasculitis and her oral prednisolone was increased to 60 mgr/day (1 mg/Kg). Further deterioration in her BCVA was noted when the patient was reviewed 3 days later. Fundus examination revealed moderate to severe vitritis, retinitis and development of typical “pizza-pie” appearance of CMV retinitis was noted (Figure 1). The right eye was uninvolved. Based on the clinical manifestations, the patient was initiated on intravenous gancyclovir 5 mg/kg twice a day.
Figure 1

Color photograph showing retinitis with scatter retinal hemorrhages in the peripapillary area and along the vascular arcades. Fundal details appear blurred due to coexisting vitritis.

Ten days later there was no further progression of retinitis and vitritis was minimal. Subsequently the first signs of improvement were apparent, with regression of exudates, reduction of retinal hemorrhages and development of retinal pigment epithelial changes. Gancyclovir was reduced to 5 mgr/kgr once a day and it was discontinued two months following complete regression of CMV retinitis (Figure 2).
Figure 2

Regression of retinitis following treatment with ganciclovir, leaving retinal pigment epithelial changes and pale optic disc.

Four months later, in the last follow-up examination, the patient’s vision remained stable at presentation levels.

Discussion

Ocular disease occurs in 29% to 58% of patients with Wegener’s granulomatosis. The three main categories of ocular involvement are scleritis with or without peripheral keratitis, orbital disease, and vasculitis-mediated vascular complications (Haynes et al 1977; Hoffman et al 1992). With the advent of corticosteroid and especially cytotoxic drugs, which altered the outlook for the disease, the prognosis of Wegener’s granulomatosis has improved considerably. However, the use of immunomodulators may be associated with several systemic adverse effects and since the patients’ immune system is compromised there is a potentially increased risk of opportunistic infections. Interestingly, CMV retinitis is extremely rare when associated with Wegener’s granulomatosis (Nicholson 1975; Riordan-Eva et al 1993; Tanihar et al 1993; Tugal-Tutkun et al 2000; Bertelmann et al 2005). In the case described above the minimal signs of retinitis and the minimal amount of vitritis, on presentation lead to the diagnosis of Wegener’s vasculitis. Wegener’s granulomatosis is always related to arteritis while CMV retinitis, which more frequently starts from the periphery, is related to vasculitis. Interestingly, in our case, infection was started from the posterior pole involving the optic disc and the peripappilary area. This case points out that the possibility of CMV retinitis, although very rare, should not be overlooked in patients with Wegener’s granulomatosis. Increased awareness in these patients is very important especially if we consider that CMV retinitis may present with less typical manifestations making the correct diagnosis more challenging. Prompt treatment with administration of antiviral agents is mandatory for the arrest of retinitis progression, earlier rehabilitation and prevention of more sinister complications.
  8 in total

Review 1.  Cytomegalovirus infection of the retina.

Authors:  D H Nicholson
Journal:  Int Ophthalmol Clin       Date:  1975

Review 2.  Cytomegalovirus retinitis in Wegener's granulomatosis: case report and review of the literature.

Authors:  Eckart Bertelmann; Anja Liekfeld; Uwe Pleyer; Christian Hartmann
Journal:  Acta Ophthalmol Scand       Date:  2005-04

3.  Wegener's granulomatosis with rapidly progressive retinitis and anterior uveitis.

Authors:  H Tanihara; Y Nakayama; Y Honda
Journal:  Acta Ophthalmol (Copenh)       Date:  1993-12

4.  Cytomegalovirus retinitis in a patient with Wegener's granulomatosis.

Authors:  I Tugal-Tutkun; N Kir; A Gül; M Koniçe; M Urgancioglu
Journal:  Ophthalmologica       Date:  2000       Impact factor: 3.250

Review 5.  The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature.

Authors:  B F Haynes; M L Fishman; A S Fauci; S M Wolff
Journal:  Am J Med       Date:  1977-07       Impact factor: 4.965

6.  Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus.

Authors:  P Pertel; R Hirschtick; J Phair; J Chmiel; L Poggensee; R Murphy
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

7.  Wegener granulomatosis: an analysis of 158 patients.

Authors:  G S Hoffman; G S Kerr; R Y Leavitt; C W Hallahan; R S Lebovics; W D Travis; M Rottem; A S Fauci
Journal:  Ann Intern Med       Date:  1992-03-15       Impact factor: 25.391

8.  Retinal neovascularization secondary to cytomegalovirus retinitis in Wegener's granulomatosis.

Authors:  P Riordan-Eva; C E Williams; A J Wing; E M Graham; M D Sanders
Journal:  J R Soc Med       Date:  1993-05       Impact factor: 18.000

  8 in total
  3 in total

1.  Acute stroke and cytomegalovirus encephalitis: a coincidence?

Authors:  Michael Harzheim; Bernd Sommer; Dieter Pöhlau
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

2.  Cytomegalovirus retinitis treated with valganciclovir in Wegener's granulomatosis.

Authors:  Yoshiaki Kabata; Genichiro Takahashi; Hiroshi Tsuneoka
Journal:  Clin Ophthalmol       Date:  2012-03-27

3.  Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients-case report and comprehensive review of the literature.

Authors:  Kenneth M Downes; Dariusz Tarasewicz; Laurie J Weisberg; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.